TREATMENT READING

Myelodysplastic/Myeloproliferative Neoplasms

Choose a source section by treatment, subtype or setting. Patient and professional reading are labelled separately.

Selected text from the National Cancer Institute, with original links and dates. This Triangle reading page is not an NCI PDQ summary. Source topics may be broader than an individual diagnosis.

Find a treatment or settingReading level

Explore 1 related disease and treatment settings → · Source-derived catalogue; clinical review pending.

17 sections · Source headings, not a ranked treatment list

For patients · Chronic Myelomonocytic Leukemia

Certain factors affect prognosis (chance of recovery) and treatment options.

For patients

Treatment Option Overview

For patients · Treatment Option Overview

Key Points

For patients · Treatment Option Overview

There are different types of treatment for patients with myelodysplastic/myeloproliferative neoplasms.

For patients · Treatment Option Overview

The following types of treatment are used:

For patients · Treatment Option Overview / The following types of treatment are used:

Watchful waiting

For patients · Treatment Option Overview / The following types of treatment are used:

Chemotherapy

For patients · Treatment Option Overview / The following types of treatment are used:

Other drug therapy

For patients · Treatment Option Overview / The following types of treatment are used:

Stem cell transplant

For patients · Treatment Option Overview / The following types of treatment are used:

Supportive care

For patients · Treatment Option Overview / The following types of treatment are used:

Targeted therapy

For patients · Treatment Option Overview

New types of treatment are being tested in clinical trials.

For patients · Treatment Option Overview

Treatment for myelodysplastic/myeloproliferative neoplasms may cause side effects.

For patients · Treatment Option Overview

Follow-up care may be needed.

For patients

Treatment of Chronic Myelomonocytic Leukemia

For patients

Treatment of Atypical Chronic Myeloid Leukemia

For patients

Treatment of Myelodysplastic/ Myeloproliferative Neoplasm, Unclassifiable

Preserved source evidence · Independent clinical review pending · Not medical advice